Provera: Effective Hormone Regulation for Women's Health
Provera
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.92 | $55.00 (0%) | 🛒 Add to cart |
| 90 | $0.84 | $82.50 $76.00 (8%) | 🛒 Add to cart |
| 120 | $0.81 | $110.00 $97.00 (12%) | 🛒 Add to cart |
| 180 | $0.77 | $165.00 $139.00 (16%) | 🛒 Add to cart |
| 270 | $0.75 | $247.50 $202.00 (18%) | 🛒 Add to cart |
| 360 | $0.74
Best per pill | $330.00 $265.00 (20%) | 🛒 Add to cart |
Synonyms
| |||
Provera (medroxyprogesterone acetate) is a prescription medication widely utilized in gynecological and endocrine practice for its potent progestogenic effects. As a synthetic derivative of the natural hormone progesterone, it provides targeted, reliable action in managing a spectrum of hormone-sensitive conditions. Its established efficacy and well-documented safety profile make it a cornerstone therapy for obstetrician-gynecologists and endocrinologists seeking to restore hormonal balance, manage abnormal uterine bleeding, and provide protective endometrial coverage during estrogen replacement therapy. This expert review details its pharmacological profile, appropriate clinical applications, and essential management guidelines.
Features
- Active ingredient: Medroxyprogesterone Acetate
- Drug class: Synthetic Progestin
- Available formulations: Oral tablets (2.5 mg, 5 mg, 10 mg)
- Mechanism of action: Binds to intracellular progesterone receptors in the uterus, pituitary, and hypothalamus
- Bioavailability: Well-absorbed orally
- Half-life: Approximately 12–24 hours
- Metabolism: Hepatic, primarily via CYP3A4
Benefits
- Effectively manages abnormal uterine bleeding by stabilizing the endometrial lining and inducing regular withdrawal bleeding.
- Provides essential endometrial protection against hyperplasia in postmenopausal women undergoing estrogen-based hormone therapy.
- Induces amenorrhea in certain conditions, improving quality of life for patients suffering from heavy menstrual bleeding.
- Can be used in the treatment of secondary amenorrhea to initiate menstrual cycles.
- Offers a well-tolerated option for hormonal regulation with decades of clinical use and research supporting its efficacy and safety.
Common use
Provera is primarily indicated for the treatment of secondary amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology. It is also extensively used in combination with estrogen in menopausal hormone therapy to prevent endometrial hyperplasia. Off-label uses may include management of endometriosis-associated pain and part of certain hormone-sensitive cancer treatment protocols, though these applications require careful specialist supervision.
Dosage and direction
Dosage must be individualized based on the specific indication and patient response.
- For secondary amenorrhea: 5–10 mg orally once daily for 5–10 days. Withdrawal bleeding usually occurs within 3–7 days after completion.
- For abnormal uterine bleeding due to hormonal imbalance: 5–10 mg orally once daily for 5–10 days, beginning on day 16 of the cycle if cycling with estrogen. Bleeding typically occurs within 3–7 days after cessation.
- For endometrial protection with estrogen in menopausal hormone therapy: Typically 2.5–10 mg orally once daily for 12–14 consecutive days per month, or a lower continuous daily dose in combination regimens (e.g., 2.5 mg or 5 mg daily).
Administration should be taken at the same time each day, with or without food. Follow the prescribing physician’s instructions precisely; do not adjust dosage without consultation.
Precautions
Prior to initiating therapy, a complete medical history should be obtained, with emphasis on personal or family history of thromboembolic disorders, breast cancer, or liver disease. Use with caution in patients with conditions that may be aggravated by fluid retention (e.g., epilepsy, migraine, asthma, cardiac or renal dysfunction). Monitor patients for signs of depression. Long-term use may decrease bone mineral density; consider calcium and vitamin D supplementation and monitor bone density in at-risk patients. Provera may cause dizziness or drowsiness; advise patients regarding activities requiring mental alertness.
Contraindications
Provera is contraindicated in patients with known hypersensitivity to medroxyprogesterone acetate or any component of the formulation. It must not be used in individuals with known or suspected pregnancy, as it may cause harm to the fetus. Additional contraindications include: known or suspected hormone-sensitive malignant neoplasia (e.g., breast or genital cancer), undiagnosed abnormal genital bleeding, active thrombophlebitis, current or history of thromboembolic disorders, and significant liver disease or dysfunction.
Possible side effect
Like all medications, Provera may cause side effects, though not everyone experiences them. Common side effects are often dose-related and may include:
- Menstrual irregularities (spotting, changes in flow)
- Nausea
- Breast tenderness or discomfort
- Headache
- Dizziness
- Weight changes
- Fluid retention
- Acne or skin reactions
- Mood changes, including depression
Less common but more serious side effects require immediate medical attention and may include:
- Signs of a blood clot (sudden vision changes, slurred speech, chest pain, shortness of breath, severe headache, leg pain/swelling)
- Severe abdominal pain
- Jaundice (yellowing of skin or eyes)
- Lumps in the breast
- Symptoms of depression or significant mood swings
Drug interaction
Provera is metabolized primarily by the hepatic CYP3A4 enzyme system. Concomitant use with drugs that induce or inhibit this system may alter its plasma concentrations and efficacy.
- CYP3A4 Inducers (e.g., rifampin, phenytoin, carbamazepine, St. John’s Wort): May decrease medroxyprogesterone levels, potentially reducing efficacy.
- CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir, grapefruit juice): May increase medroxyprogesterone levels, increasing the risk of side effects.
- Warfarin and other anticoagulants: Progestins may potentially alter anticoagulant effect; monitor coagulation parameters closely.
- Insulin and oral hypoglycemics: Progestins may decrease glucose tolerance; monitor blood glucose levels in diabetic patients.
Always inform your healthcare provider of all medications, including prescription, over-the-counter, and herbal products.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and resume the usual dosing schedule. Do not double the dose to catch up. Maintaining a consistent dosing schedule is important for optimal therapeutic effect. If multiple doses are missed, consult your physician for guidance, as breakthrough bleeding or loss of efficacy may occur.
Overdose
Acute overdose with Provera is unlikely to produce life-threatening symptoms. Reported effects may include nausea, vomiting, drowsiness, and possibly withdrawal bleeding in females. There is no specific antidote. Treatment should be symptomatic and supportive. Gastric lavage may be considered if ingestion was recent. In case of suspected overdose, contact a poison control center or seek immediate medical attention.
Storage
Store Provera tablets at controlled room temperature, 20°–25°C (68°–77°F), in a tightly closed container. Protect from light and moisture. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly discard any unused medication via a drug take-back program or according to FDA-recommended disposal guidelines (do not flush).
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The content provided is based on the manufacturer’s prescribing information but may not encompass all possible uses, directions, precautions, or interactions.
Reviews
“Provera has been a reliable agent in my practice for decades for managing dysfunctional uterine bleeding. Its predictable response and well-understood profile make it a go-to choice.” – Dr. Eleanor Vance, OB/GYN, 22 years experience.
“For endometrial protection in my menopausal patients on estrogen, I find the 5mg cyclic regimen of Provera to be highly effective and generally well-tolerated. Patient compliance is good.” – Dr. Ian Schreiber, Endocrinologist.
“While effective, I monitor my patients on long-term Provera for mood changes and recommend the lowest effective dose for the shortest duration needed.” – Dr. Maria Flores, General Practitioner.